Lupin Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lupin Ltd with three other
companies in this sector in India:
sales of 143.94 billion Indian Rupees [US$2.21 billion]
of which 101%
Aurobindo Pharma Ltd
(149.10 billion Indian Rupees [US$2.28 billion]
of which 100%
was Pharmaceuticals), and
Dr.Reddy's Laboratories Ltd
(140.81 billion Indian Rupees [US$2.16 billion]
of which 82%
was Global Generics).
Lupin Ltd reported sales of 174.94 billion Indian Rupees (US$2.68 billion)
March of 2017.
increase of 23.1%
versus 2016, when the company's sales were 142.08 billion Indian Rupees.
Sales at Lupin Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 151%).